Literature DB >> 17093448

Spider toxins activate the capsaicin receptor to produce inflammatory pain.

Jan Siemens1, Sharleen Zhou, Rebecca Piskorowski, Tetsuro Nikai, Ellen A Lumpkin, Allan I Basbaum, David King, David Julius.   

Abstract

Bites and stings from venomous creatures can produce pain and inflammation as part of their defensive strategy to ward off predators or competitors. Molecules accounting for lethal effects of venoms have been extensively characterized, but less is known about the mechanisms by which they produce pain. Venoms from spiders, snakes, cone snails or scorpions contain a pharmacopoeia of peptide toxins that block receptor or channel activation as a means of producing shock, paralysis or death. We examined whether these venoms also contain toxins that activate (rather than inhibit) excitatory channels on somatosensory neurons to produce a noxious sensation in mammals. Here we show that venom from a tarantula that is native to the West Indies contains three inhibitor cysteine knot (ICK) peptides that target the capsaicin receptor (TRPV1), an excitatory channel expressed by sensory neurons of the pain pathway. In contrast with the predominant role of ICK toxins as channel inhibitors, these previously unknown 'vanillotoxins' function as TRPV1 agonists, providing new tools for understanding mechanisms of TRP channel gating. Some vanillotoxins also inhibit voltage-gated potassium channels, supporting potential similarities between TRP and voltage-gated channel structures. TRP channels can now be included among the targets of peptide toxins, showing that animals, like plants (for example, chilli peppers), avert predators by activating TRP channels on sensory nerve fibres to elicit pain and inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093448     DOI: 10.1038/nature05285

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  110 in total

1.  Neuromechanical representation of fabric-evoked prickliness: a fiber-skin-neuron model.

Authors:  Hu Jiyong; Li Yi; Ding Xin; Hu Junyan
Journal:  Cogn Neurodyn       Date:  2010-12-01       Impact factor: 5.082

2.  Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier.

Authors:  Asher Peretz; Liat Pell; Yana Gofman; Yoni Haitin; Liora Shamgar; Eti Patrich; Polina Kornilov; Orit Gourgy-Hacohen; Nir Ben-Tal; Bernard Attali
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

Review 3.  TRPs and pain.

Authors:  Yi Dai
Journal:  Semin Immunopathol       Date:  2015-09-15       Impact factor: 9.623

4.  Constitutive activity of TRP channels methods for measuring the activity and its outcome.

Authors:  Shaya Lev; Baruch Minke
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

Review 5.  Receptor-targeting mechanisms of pain-causing toxins: How ow?

Authors:  Christopher J Bohlen; David Julius
Journal:  Toxicon       Date:  2012-04-14       Impact factor: 3.033

6.  Voltage is a partial activator of rat thermosensitive TRP channels.

Authors:  José A Matta; Gerard P Ahern
Journal:  J Physiol       Date:  2007-10-11       Impact factor: 5.182

Review 7.  From chills to chilis: mechanisms for thermosensation and chemesthesis via thermoTRPs.

Authors:  Michael Bandell; Lindsey J Macpherson; Ardem Patapoutian
Journal:  Curr Opin Neurobiol       Date:  2007-08-13       Impact factor: 6.627

8.  Portability of paddle motif function and pharmacology in voltage sensors.

Authors:  Abdulrasheed A Alabi; Maria Isabel Bahamonde; Hoi Jong Jung; Jae Il Kim; Kenton J Swartz
Journal:  Nature       Date:  2007-11-15       Impact factor: 49.962

Review 9.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 10.  TRP channels: potential drug target for neuropathic pain.

Authors:  Lovish Marwaha; Yashika Bansal; Raghunath Singh; Priyanka Saroj; Ranjana Bhandari; Anurag Kuhad
Journal:  Inflammopharmacology       Date:  2016-10-18       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.